Becton Dickinson (BDX) Other Non-Current Assets (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Other Non-Current Assets of $3.0 billion for Q4 2025, up 17.36% year-over-year from $2.6 billion in Q4 2024, and up 43.57% quarter-over-quarter from $2.1 billion in Q3 2025.
Becton Dickinson (BDX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Other Non-Current Assets for 17 consecutive years, with $3.0 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 17.36% year-over-year to $3.0 billion; the TTM figure through Dec 2025 stood at $3.0 billion (up 17.36% YoY), while the FY2025 annual figure was $2.1 billion, down 19.16% from the prior year.
- Other Non-Current Assets climbed to $3.0 billion in Q4 2025 per BDX's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.0 billion in Q4 2025 and bottomed at $271.0 million in Q2 2023.
- Historically, Other Non-Current Assets has averaged $2.0 billion across 5 years, with a median of $2.1 billion in 2023.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets tumbled 74.93% — and 2024, when it surged 785.98%.
- Becton Dickinson's Other Non-Current Assets stood at $1.9 billion in 2021, then advanced by 0.51% to $2.0 billion in 2022, then rose by 15.55% to $2.3 billion in 2023, then advanced by 14.48% to $2.6 billion in 2024, then increased by 17.36% to $3.0 billion in 2025.
- Business Quant data shows BDX's Other Non-Current Assets at $3.0 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.7 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 452.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Bn |
| Mar 31, 2026 | 2.43 Bn |
| Dec 31, 2025 | 3.04 Bn |
| Sep 30, 2025 | 2.11 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.58 Bn |
| Dec 31, 2024 | 2.59 Bn |
| Sep 30, 2024 | 2.62 Bn |
| Jun 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 2.40 Bn |
| Dec 31, 2023 | 2.26 Bn |
| Sep 30, 2023 | 2.08 Bn |
| Jun 30, 2023 | 271.00 Mn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 1.96 Bn |
| Sep 30, 2022 | 1.85 Bn |
| Mar 31, 2022 | 1.87 Bn |
| Dec 31, 2021 | 1.95 Bn |
| Sep 30, 2021 | 423.00 Mn |
| Jun 30, 2021 | 1.82 Bn |